{"name":"SK Life Science, Inc.","slug":"sk-life-science-inc","ticker":"","exchange":"","domain":"sklifescience.com","description":"","hq":"Fair Lawn","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":11,"colorKey":"oncology","drugs":[{"name":"Omeprazole Pill","genericName":"Omeprazole Pill","slug":"omeprazole-pill","indication":"Other","status":"phase_1"},{"name":"Bupropion Pill","genericName":"Bupropion Pill","slug":"bupropion-pill","indication":"Other","status":"phase_1"},{"name":"Cenobomate Oral Suspension Fasted","genericName":"Cenobomate Oral Suspension Fasted","slug":"cenobomate-oral-suspension-fasted","indication":"Other","status":"phase_1"},{"name":"Cenobamate Oral Suspension Fed","genericName":"Cenobamate Oral Suspension Fed","slug":"cenobamate-oral-suspension-fed","indication":"Other","status":"phase_1"},{"name":"SKL11197","genericName":"SKL11197","slug":"skl11197","indication":"Other","status":"phase_2"},{"name":"SKL15508","genericName":"SKL15508","slug":"skl15508","indication":"Other","status":"phase_1"},{"name":"SKL24741","genericName":"SKL24741","slug":"skl24741","indication":"Other","status":"phase_1"},{"name":"Warfarin Pill","genericName":"Warfarin Pill","slug":"warfarin-pill","indication":"Other","status":"phase_1"},{"name":"YKP10811","genericName":"YKP10811","slug":"ykp10811","indication":"Other","status":"phase_2"},{"name":"YKP10811 Drug Product Capsule","genericName":"YKP10811 Drug Product Capsule","slug":"ykp10811-drug-product-capsule","indication":"Other","status":"phase_2"},{"name":"YKP3089","genericName":"YKP3089","slug":"ykp3089","indication":"Other","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Xcopri","genericName":"Xcopri","slug":"xcopri","indication":"Epilepsy having focal-onset seizures","status":"marketed"}]}],"pipeline":[{"name":"Omeprazole Pill","genericName":"Omeprazole Pill","slug":"omeprazole-pill","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Bupropion Pill","genericName":"Bupropion Pill","slug":"bupropion-pill","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cenobomate Oral Suspension Fasted","genericName":"Cenobomate Oral Suspension Fasted","slug":"cenobomate-oral-suspension-fasted","phase":"phase_1","mechanism":"Cenobomate reduces neuronal excitability through dual mechanisms: inhibition of voltage-gated sodium channels and positive allosteric modulation of GABA-A receptors.","indications":[],"catalyst":""},{"name":"Cenobamate Oral Suspension Fed","genericName":"Cenobamate Oral Suspension Fed","slug":"cenobamate-oral-suspension-fed","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SKL11197","genericName":"SKL11197","slug":"skl11197","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SKL15508","genericName":"SKL15508","slug":"skl15508","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SKL24741","genericName":"SKL24741","slug":"skl24741","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Warfarin Pill","genericName":"Warfarin Pill","slug":"warfarin-pill","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Xcopri","genericName":"Xcopri","slug":"xcopri","phase":"marketed","mechanism":"Gamma-aminobutyric acid receptor subunit alpha-4, Gamma-aminobutyric acid receptor subunit alpha-6","indications":["Epilepsy having focal-onset seizures","Partial seizure"],"catalyst":""},{"name":"YKP10811","genericName":"YKP10811","slug":"ykp10811","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"YKP10811 Drug Product Capsule","genericName":"YKP10811 Drug Product Capsule","slug":"ykp10811-drug-product-capsule","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"YKP3089","genericName":"YKP3089","slug":"ykp3089","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5ZRl9mbnNWOTZwM05UVHhlMzM2YVV5SGZiU0pIS0FtUG4wOWxOdi14Q1lZLUhNNndXTS1hRkloRVlnLU1IYThJYTF4MHZKRHFOaDV6bGNHUm1KeFkzZ3NGNHJhM0FHc0NZMGRQNFJ30gFyQVVfeXFMUE1sSDZDOE9Jc2ktLVJjOVlVSUx0N2xsYmNTVHNXaVRoZjlfUHJSUkFwWFNMMkNIQ3Atd2VTWEFVOWlKY3VqS284NVhVcFFSVURVWWZKQURIVFBoZGh0V0QyTVlscmdzaDBqMUE2dTAwNHRB?oc=5","date":"2025-12-08","type":"pipeline","source":"koreabiomed.com","summary":"SK biopharmaceuticals aligns global strategy for epilepsy drug cenobamate at AES 2025 - koreabiomed.com","headline":"SK biopharmaceuticals aligns global strategy for epilepsy drug cenobamate at AES 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNQ1BqSzRhWVVfNW1uS1lhZGN0RzhYRjFXYWxiSkNCQWR4TURiRms4SUxfUml4VGdhaElzMi03ZDA0T2Y5TFRIQ3FKdXNweWU4WXJEQU42eDRCZy1ST3JLenhJalltaWRTcjh0UnlHMGQ0Z2Z6MDNyeHBiUVBfRVBiaDRNMTJUWFJ2M1pNZEppLXN6bEl5c2xXaTlJbjk1RWFsN2c?oc=5","date":"2025-11-24","type":"regulatory","source":"Fierce Pharma","summary":"SK Life Science Xcopri ad meets a roadblock with FDA untitled letter - Fierce Pharma","headline":"SK Life Science Xcopri ad meets a roadblock with FDA untitled letter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPM3BtbmxSZU9xYXlYNzMyQm10V1lBck1oQXA3LXFaV3V0and0cGFiTUwyQkc4Q0h0VkhreEhYbXBDdHNTZlVnRmRQVEtEM1hXeFVKZWNaeFNwUVNqZnJLdTBOX3lDZFVsLXQyNFd3aWUyeUxqQW5MY2plUU1BUXQ2N0hvQ2RMY09MNzk5ZHFtY3EtMHlyMVV4aVZfZjNKcTBPTVZoQk42Rl90ZW96VERIRHBNUlFqMlBUTkV6ZnpXcENSUktsY1hPYXdXSDBOQ3ljakNxaWFfRGUwOGdHeXc?oc=5","date":"2025-11-17","type":"trial","source":"PR Newswire","summary":"SK Life Science, Inc. Announces Publication of C035 Study Analyses in Epilepsia and Seizure - PR Newswire","headline":"SK Life Science, Inc. Announces Publication of C035 Study Analyses in Epilepsia and Seizure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNUFEwQWdlUndSV1d6UnFzWlZDREp6RWZuN3FranFRT25TQk5Db1A3QUJoRHYwUkdFQXlwNE5fZThhR015bjVJeVBlczFGck9CLVVJdnFCRVc1eEE4dHg0ODJ1cjVyZi1jTnViN3c3RUZqM2JHRGIwTkpyTnZGOGpLLWJManZjaG9QQTljVEdiU2ZTblRTUEFtX0pnZGZiWkxYV3Q4ZVVSVVQzV2FqT3VRU051dTE2bHQxS0E?oc=5","date":"2025-10-21","type":"pipeline","source":"Invest Ontario","summary":"SK Biopharmaceuticals launches AI digital health business with Eurofarma in Ontario - Invest Ontario","headline":"SK Biopharmaceuticals launches AI digital health business with Eurofarma in Ontario","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPMW1jb1NCSnFLRVVINXFianoxbTd6Y1lFQ2RNNHJZVzYxb2JUczRzajdPc2d0RVQ2eDlZWENZZ1VSZkZBRUlJSGdKblFNU3ctbkV1MkI0aVdETFctUTZ6TVg0UldXaHVnWGxXcVlkaWdPNnIwa0VXRWN4cVJLYWstOXloQXIyaDNQcDAwYnRNQjVvN3AxaVdBaEt4MEhhT0MzQmc?oc=5","date":"2025-08-25","type":"pipeline","source":"NYU Langone Health","summary":"Most Epilepsy Patients Wait a Year After Starting Treatment for Seizure Relief - NYU Langone Health","headline":"Most Epilepsy Patients Wait a Year After Starting Treatment for Seizure Relief","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5HR3VkTTJnTEo0V0JZRjVkQWFUTEozd1JHaGxaRk93ejhwQXh0RFdmb0gzZ1lfaTZwaVlodUxWNFpFZVhPZVgxLWx1cDdGb2lJZnlHS2xlZzlsVkYxbGdwMXJkaFpNWml1d2FjVFN30gFyQVVfeXFMTmw5c09INm53ZGZwcmtNNWM0QmRXOWxobXRSYmRRZFczUkhRN2FiSktxakkybFQtb1dDTS15TmF2aDFXaXpTOWlLOWtodUo3cVlpeWhJTHdwYkhXNEVUbENyQnFDMkJTajdBSzZqN1UwMHdn?oc=5","date":"2025-05-09","type":"earnings","source":"koreabiomed.com","summary":"SK biopharmaceuticals' Q1 earnings solid on strong US cenobamate sales - koreabiomed.com","headline":"SK biopharmaceuticals' Q1 earnings solid on strong US cenobamate sales","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxPcnZQNEdfMHpuUXFtVmh2cU9Ec09oOXpMblhieWYxQzFLNF9IS0FkMzNrSzIxSDR5VXRuNkRxaGFFc0hCQk5xVUhiMnlkWHlaTnNFbW1YUnpYYVY1S0Ryd0JaV1llVUVYdW1BQjZlZnRlQUFRSHVmcl8wWDF1eTRiSjdkR0pDQnBKc2kxbkRhRnNEbzFPb281TGcydFpfSlJMVkw5dm43enFSR091dDFWd2owczhoVEhRRFBJTldzU29Jc3ZtYVhrNTdfNkFhUS1DbHcwOUVkTHQwblFpd3BuR2hTak5ZN1VvVHQ1WkxHb2liQ21BNmRadENZOFZaeTR0OWl5LWtfU0FZamN1d1VtVTd4ZzRBSDlvNC1BUlFYdUFnR2pOZWlhdjlGS0tiOFg3M1NqZVdzZzQ0NWR4TUdiLWItQzZkSXJDaHNkM21B?oc=5","date":"2025-04-29","type":"pipeline","source":"BioSpace","summary":"Late-Breaking Research from SK Life Science Labs at AACR Annual Meeting Shows p300-Selective Degraders are Potent Growth Inhibitors in Models of Aggressive Prostate Cancers and Solid Tumors - BioSpace","headline":"Late-Breaking Research from SK Life Science Labs at AACR Annual Meeting Shows p300-Selective Degraders are Potent Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5JSHM1LTlQbkY0cE9kVk5BQjVvRTU2SXBkbHI1dV9mc1VCeFVzbkFvR3NsSXM2bVIxb3Nxb0NDMWEzR2VjTDRPZTl6dDVmUlFLTm5tOHk1MS0ybEMwYWhIQ19hM1d1cFJIdmtDMk530gFyQVVfeXFMUFI0QzZWWVpJT09KOGhEUS0xZmgzTS1LVHZYZE5fT3R5S2NqQnFpQ01mbzlnb0tWUVVUN19vUXh6VS1NRnotRWxRVGFXRkM3cGVvRE9uOUFnVXN5Z1NrQ0xiMTBkaE10eGxDQ25jc2FtTWNn?oc=5","date":"2025-02-17","type":"pipeline","source":"koreabiomed.com","summary":"SK biopharmaceuticals strengthens global R&D with new hires at US subsidiary - koreabiomed.com","headline":"SK biopharmaceuticals strengthens global R&D with new hires at US subsidiary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgJBVV95cUxPdUhndFVqMnFhZlZqUzFVaHlTWXdlRjZMWXhtSnZQejcxUmJ1aUhIUXNIWnBMVWh0Q3RmcHliSUtjZXktOW5nZVViWmlleWRwTHdYbnJrZ0dnUVpHUjhoX2YyX0tEdlZ5WXFIT2tjTXFZUWJKVFZTNDdtMExFZUphejRyQTNUZnRoWlB1VnJIbWpPbnBCN0JSWlhIMk0wanNsYUdDMU80Z1ItaFlXR19EQmh4YmxnWkNuWVNGQk5Ham1VTTllYnlaVTZ0TkJjaHVFM2hnQXVIUGpicjhLaFJXbHFUZE9NbWxHN0RLSTY3WVd3dGZCVDA4TDdNc2lpazFaeVNmRENySVcxOHpFRDQ5U0t0UWVyTTdNRGpORlRFYmNURzdkMzFMenZtV0V0bHNMQXQ2OWdKOGZXZHQzTVVzWTZB?oc=5","date":"2024-12-08","type":"trial","source":"PR Newswire","summary":"SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate's Dual Mechanism of Action - PR Newswire","headline":"SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Unde","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPSG1IS215a19tajU2ZzZJYUx3N3hoa2szWHJ5RkQ5NVFwQUJKVUtPcVp5TnVpR19Za3BFWWg2dnBid29yTWZzeTF4NXJaWnJtd2hqaXJKQ0w5TGZvVnpQUm0wX1ZXZmI1RVVjX2JYazZkY2dWdlUtblRaRmFZNjRvNzg3cTlBWm1JSDdUZkc2S1ZTSlkxTFZQR2dIeVlVcGRUeFotT2VHdjBXQlBrSkdqVWI4cUlJMHNKbGFMRml3?oc=5","date":"2024-07-11","type":"pipeline","source":"pharmaphorum","summary":"SK Life Science Leverages Smart, Efficient Solutions Across its Engaged Industry-Leading Sales Team - pharmaphorum","headline":"SK Life Science Leverages Smart, Efficient Solutions Across its Engaged Industry-Leading Sales Team","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNNDE3YWZfWHdMOHFPN25GRFRxa08zb3hQNlMzZjVHaWsxUlpXTDNjNl9YWm5xLU1MeGV6UXNDLWZGR1pUX196UFl1OXZFSEhSZkNoam8zWVhOS0JidGg5MlU0QXl6NEdrbXctdXBhOWo4TVo5cjBxX0R5TWF2N3lTWVJkandhUXZSa0JTY0s3dWJGQUtHcnc1NnhQdk0xRXZpOUhCekd3cVVNa1ZlODRZTk1UX0xKOUdfVDRrZmJ1eFlzSzU5dWV1N29BMWNQTy03MnM5QTFtTVV5MGJfNXc?oc=5","date":"2024-01-11","type":"pipeline","source":"Veeva","summary":"Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency - Veeva","headline":"Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPUVY3TTJPZEpXdERCUEY3dXR2ek1oZlA0aF9hY3NIMlFYNkRtUEtVaXRDaW8wY2JBb3VxY25EcGZaQUwzeHVCOHFDM3pxZ3VGVmRWenNpRFhVdXVzQ0tzNUs1OC1yUDNxUmMzRElUUWxBSTNvT0swU1hkZHFkNVM5b1QyZnBFc0ZQXzRieXRTdzlzbTFmVlZvZzdoZ2c?oc=5","date":"2024-01-11","type":"pipeline","source":"Contract Pharma","summary":"SK Biopharmaceuticals Adopts Veeva Vault Validation Management - Contract Pharma","headline":"SK Biopharmaceuticals Adopts Veeva Vault Validation Management","sentiment":"neutral"}],"patents":[],"drugCount":12,"phaseCounts":{"phase_1":7,"phase_2":3,"marketed":1,"phase_3":1},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}